Molecular targets for radiation oncology in prostate cancer.
about
Therapeutic Implications for Overcoming Radiation Resistance in Cancer TherapyRAD9 enhances radioresistance of human prostate cancer cells through regulation of ITGB1 protein levels.β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1.Kinesin light chain-4 depletion induces apoptosis of radioresistant cancer cells by mitochondrial dysfunction via calcium ion influx.Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device.
P2860
Molecular targets for radiation oncology in prostate cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular targets for radiation oncology in prostate cancer.
@en
type
label
Molecular targets for radiation oncology in prostate cancer.
@en
prefLabel
Molecular targets for radiation oncology in prostate cancer.
@en
P2093
P2860
P356
P1476
Molecular targets for radiation oncology in prostate cancer
@en
P2093
Gary Stein
Michael Blute
Thomas J Fitzgerald
P2860
P356
10.3389/FONC.2011.00017
P577
2011-07-13T00:00:00Z